Article
Should newborn mutation scanning for hyperphenylalaninaemia and galactosaemia be implemented? A Polish experience.
Journal of medical screening - 1 Jan 2001
Zekanowski C, Nowacka M, Radomyska B, Cabalska B
Abstract excerpt
OBJECTIVE: To elucidate whether screening for mutations causing hyperphenylalaninaemia (HPA) and classic galactosaemia could provide important, additional information on a clinical phenotype. METHOD: Genotypes that cause disease at the phenylalanine hydroxylase (PAH) gene and galactose-1-phosphate uridyltransferase (GALT) gene in a group of 101 hyperphenylalaninaemic and 77 patients with classic galactosaemia...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
